Related Experiment Video
Updated: Sep 3, 2025

07:44
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
1.3K
Significant Decrease in Glycated Hemoglobin, 2h-Post-Load Glucose and High-Sensitivity C-Reactive Protein Levels in
Klaudia Antoniak1, Katarzyna Zorena1, Marta Jaskulak1
1Department of Immunobiology and Environment Microbiology, Medical University of Gdansk, Dębinki 7, 80-211 Gdansk, Poland.
Biomedicines
|July 27, 2022
Summary
Manual lymphatic drainage (MLD) may improve metabolic health in individuals with abnormal body mass index. This therapy showed positive effects on insulin resistance, C-peptide, and hsCRP levels, particularly in overweight and obese patients.
Area of Science:
- Endocrinology and Metabolism
- Physiotherapy and Rehabilitation
- Biochemistry
Background:
- Abnormal body mass index (BMI) is associated with metabolic dysfunction, including insulin resistance and inflammation.
- Manual lymphatic drainage (MLD) is a therapeutic technique that aims to improve lymphatic circulation.
- The potential impact of MLD on metabolic parameters in individuals with abnormal BMI requires further investigation.
Purpose of the Study:
- To evaluate the effects of MLD on insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), C-peptide, insulin, fasting plasma glucose (FPG), 2-hour post-load glucose (2h-PG), and high-sensitivity C-reactive protein (hsCRP).
- To assess these effects in patients with normal weight, overweight, and obesity.
Main Methods:
- Thirty patients were divided into normal weight, overweight, and obese groups.
- Each participant received 10 sessions of MLD therapy over approximately 3 weeks.
- Biochemical markers and body composition (BMI, WHR, visceral adipose tissue) were measured before and after MLD intervention.
Main Results:
- Significant correlations were found between C-peptide, HOMA-IR, BMI, and visceral adipose tissue before and after MLD.
- Overweight patients showed significant reductions in hsCRP and 2h-PG levels post-MLD.
- Obese patients exhibited a significant decrease in HbA1c levels following MLD therapy.
Conclusions:
- MLD therapy demonstrated a positive influence on selected biochemical parameters in patients with abnormal BMI.
- The most favorable changes were observed in overweight individuals, suggesting MLD's potential as an adjunct therapy.
- Further research with larger cohorts is recommended to confirm these findings and explore the clinical benefits and mechanisms of MLD.

